Related Experiment Video

Updated: May 26, 2026

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
06:26

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells

Published on: February 14, 2020

Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?

M M Jack1, J M Ryals, D E Wright

  • 1Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Experimental Neurology
|December 29, 2011
PubMed

Insights

Low glyoxalase I (GLO1) expression in diabetic mice worsened neuropathy symptoms and nerve damage. Conversely, higher GLO1 levels protected against these diabetes-related complications, highlighting GLO1

Area of Science:

  • Neuroscience
  • Metabolic Disorders
  • Biochemistry

Background:

  • Diabetic neuropathy, a common complication of diabetes mellitus, affects over half of patients due to sensory nerve damage.
  • Diabetes-induced hyperglycemia accelerates advanced glycation end product (AGE) formation, leading to protein alterations and neuronal dysfunction.
  • The glyoxalase system, particularly glyoxalase I (GLO1), detoxifies AGE precursors like methylglyoxal, mitigating cellular damage.

Purpose of the Study:

  • To investigate the role of glyoxalase I (GLO1) expression levels in the development of diabetic sensory neuropathy.
  • To compare neuropathy development in mice with naturally low GLO1 expression versus those with high GLO1 expression under diabetic conditions.

Main Methods:

  • Utilized BALB/cJ mice (low GLO1) and BALB/cByJ mice (high GLO1) with varying GLO1 copy numbers.
  • Induced diabetes using streptozotocin (STZ) injection and assessed behavioral changes (mechanical thresholds) and intraepidermal nerve fiber density (IENFD) after five weeks.
  • Quantified the expression of mitochondrial oxidative phosphorylation proteins in diabetic and control mice.

Main Results:

  • Diabetic BALB/cJ mice (low GLO1) exhibited a 68% increase in mechanical thresholds and a 38% reduction in IENFD, indicative of neuropathy.
  • These mice also showed significant reductions in mitochondrial oxidative phosphorylation proteins (Complexes I and V).
  • Conversely, diabetic BALB/cByJ mice (high GLO1) did not develop neuropathy, IENFD loss, or mitochondrial alterations.

Conclusions:

  • Reduced GLO1 expression, combined with hyperglycemia, contributes to neuronal mitochondrial damage and diabetic neuropathy symptoms.
  • AGEs, the glyoxalase system, and mitochondrial dysfunction are implicated in the development and progression of diabetic peripheral neuropathy.
  • GLO1 levels may serve as a critical factor in modulating the severity of diabetic neuropathy.

More Related Videos

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...